Workshop Participants

    1.  

    Dr.Vahe Bedian, Principal Research Investigator, Pfizer Central Research

    2.  

    Dr. Arturo Casadevall, Department of Microbiology & Immunology, Albert Einstein College of Medicine

    3.  

    Dr. Joseph Chandler, President, Maine Biotechnology Services, Inc.

    4.  

    Mr. Tim DeSutter, Vice President, Integra Biosciences, Inc.

    5.  

    Dr. Louis Detolla, Chairman, Comparative Medicine Program, University of Maryland

    6.  

    Dr. Dennis Dixon, Chief, Bacteriology and Mycology Branch, Division of Microbiology and Infectious Diseases, NIH/NIAID

    7.  

    Ms. Tracie Letterman, Esquire, International Center for Technology Assessment

    8.  

    Dr. Peter Maxim, FDA/CDRH

    9.  

    Dr. John McArdle, Director, Alternatives Research and Development Foundation

    10.  

    Dr. John Reddington, DiagXotics, Inc.

    11.  

    Dr. Simon Saxby, Director, Contract Operations, Unisyn Technologies

    12.  

    Dr. Kathryn Stein, Director, Division of Monoclonal Antibodies, FDA/CBER

    13.  

    Dr. Paul E. Thomas, Professor, Department of Chemical Biology, Rutgers the State University

    14.  

    Dr. James Valdes, Edgewood Research Development & Engineering Center



    The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
    Copyright © National Academy of Sciences. All rights reserved.
    Terms of Use and Privacy Statement